Advocacy intelligence hub — real-time data for patient organizations
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran — NA
Shanghai Jiao Tong University School of Medicine — PHASE1
Brian Keller
Karolinska Institutet — NA
Centre Hospitalier Universitaire de Nīmes — NA
Zhujiang Hospital — PHASE4
Montefiore Medical Center — NA
Qing-Lei Zeng — PHASE4
Qing-Lei Zeng — PHASE4
VA Office of Research and Development — PHASE2
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Open now
Copay cards
Copay Assistance3
Dyural 80-Lm
(METHYLPREDNISOLONE ACETATE, LIDOCAINE HYDROCHLORIDE, BUPIVACAINE HYDROCHLORIDE, POVIDINE IODINE, ISOPROPYL ALCOHOL)Orphan drugstandardAdvanced Rx Pharmacy of Tennessee, LLC
12.1 Mechanism of Action Bupivacaine blocks the generation and the conduction of nerve impulses, presumably by increasing the threshold for electrical...
HUMIRA
(adalimumab)Orphan drugstandardAbbVie, Inc.
12.1 Mechanism of Action Adalimumab binds specifically to TNF-alpha and blocks its interaction with the p55 and p75 cell surface TNF receptors. Adalim...
He Huang, MD
Zhejiang University
📍 Hanzhou, Zhejiang
Guang-Shing Cheng, MD, MD
Fred Hutch/University of Washington Cancer Consortium
📍 SEATTLE, WA
Mikhail Samsonov
R-Pharm
Jiong Hu, Ph.D., Au.D
Shanghai Jiao Tong University School of Medicine
📍 SAN FRANCISCO, CA
Corey Cutler, MD, MPH, F.N.P
Dana-Farber Cancer Institute
📍 PARK CITY, UT
Robert J Kreitman, M.D., MP
National Cancer Institute (NCI)
📍 OLNEY, MD